uracil has been researched along with Cockayne Syndrome in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Cockayne Syndrome: A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klungland, A | 1 |
| Höss, M | 1 |
| Gunz, D | 1 |
| Constantinou, A | 1 |
| Clarkson, SG | 1 |
| Doetsch, PW | 1 |
| Bolton, PH | 1 |
| Wood, RD | 1 |
| Lindahl, T | 1 |
1 other study available for uracil and Cockayne Syndrome
| Article | Year |
|---|---|
Base excision repair of oxidative DNA damage activated by XPG protein.
Topics: Base Sequence; Binding Sites; Cockayne Syndrome; Deoxyribonuclease (Pyrimidine Dimer); DNA Damage; D | 1999 |